patent infringement
Justices Refuse to Hear 'Skinny Label' Drug Patent Case
2023-05-15 17:28:13
by
Dan McCue
WASHINGTON — The Supreme Court on Monday declined to review a 2020 decision by the U.S. Circuit Court of Appeals for the Federal Circuit that resulted in Teva Pharmaceuticals being found liable for $235 million for infringing on a GlaxoSmithKline... Read More
Straight From The Well